BioSpace News Archive

Business

Hologic to Announce Financial Results for the First Quarter of Fiscal 2018 on Thursday, February 8, 2018

In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.

January 8, 2018
·
1 min read
Business

Besties Regeneron and Sanofi Add Another $1B to PD-1 I/O Deal

The two companies struck the deal in 2015.

January 8, 2018
·
14 min read
Business

CytoSorbents Pre-Announces Preliminary Fourth Quarter and Full Year 2017 Results and Issues Stockholder Letter

CytoSorbents pre-announces preliminary unaudited fourth quarter 2017 and full year 2017 results ahead of filing its Form 10-K, and issues a stockholder letter from Dr. Phillip Chan, Chief Executive Officer of CytoSorbents.

January 8, 2018
·
9 min read
Business

Acorda Announces 2017 AMPYRA Net Sales and Provides 2018 Financial Guidance at J.P. Morgan Healthcare Conference

Unaudited 2017 full-year net sales were $542 million, an increase of approximately 10% from 2016.

January 8, 2018
·
8 min read
Drug Development

Ra Pharmaceuticals Initiates Dosing in Phase Ib Pharmacokinetic Study Evaluating RA101495 SC in Patients with Renal Impairment

This trial is designed to characterize the pharmacokinetics (PK) of RA101495 SC in these patients, thereby enabling the evaluation of RA101495 SC in complement-mediated renal diseases, such as atypical hemolytic uremic disorder (aHUS) and lupus nephritis (LN).

January 8, 2018
·
5 min read
Oragenics, Inc. Announces Reverse Stock Split Effective January 19, 2018

The Company’s common stock will begin trading on a split-adjusted basis when the markets open on January 22, 2018 under the existing trading symbol “OGEN”.

January 8, 2018
·
4 min read
Genetown

Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company

Sage Therapeutics today announced that in a corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco.

January 8, 2018
·
9 min read
Deals

The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics

The Company expects to provide additional details regarding its cash position and plans as part of its fourth quarter and full year 2017 financial results.

January 8, 2018
·
4 min read
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures

Acasti announces that in accordance with the terms of its outstanding convertible debentures in the total aggregate principal amount of $2,000,000 issued on February 21, 2017.

January 8, 2018
·
3 min read
Critical Outcome Technologies Changes Name to Cotinga Pharmaceuticals

The effective date of the name change, approved by shareholders in December 2017, is expected to be January 10, 2018.

January 8, 2018
·
4 min read